Form D · Biotechnology
CannTrust Inc.
Vaughan, Z4 · CIK 0001613176
Offering snapshot reported Jan 6, 2015 · SEC filing
- Reported sold
- $1M Offering amount: $1M
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Dec 31, 2014 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jan 6, 2015 | Initial | $1,000,000 | No comparison | 2 | SEC filing |
| Jul 10, 2014 | Initial | $2,786,700 | No comparison | 14 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-231520
$1,000,000 sold to 2 US Purchasers.
Source: Form D, filed Jan 6, 2015. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Ron Benson | Director |
| Mark Litwin | Director |
| Norman Paul | Director, Executive |
| Eric Paul | Director, Executive |
| Mitchell J. Sanders | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
3280 Langstaff Road, Unit 1
Vaughan, Z4, L4K4Z8
Vaughan, Z4, L4K4Z8